Océanie · Marchés régionaux · The Motley Fool Australia

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

Publié par The Motley Fool Australia · Australie il y a 2 h

Telix Pharmaceuticals' Q3 2026 update sees strong revenue growth, FDA milestones, and a major merger to expand its radiopharmaceuticals platform. The post Telix Pharmaceuticals Q3…

Lire l'article complet sur The Motley Fool Australia Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com.au)

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

À lire aussi

Woodside confirms plan to sell down $3.3b project after two years of ownership

GAMING: 6 of the best indie games from the PAX Australia show floor

Transport costs to Sydney's new airport: Is it worth it for you?

Mino Founder Mel Moss On How Her Son’s Sleep Problems Led To A New Bedding Business

Morning Wrap: ASX 200 to rise, Dow rallies on defensive pivot, S&P 500 gains on oil retreat

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

Partager

À lire aussi

Woodside confirms plan to sell down $3.3b project after two years of ownership

GAMING: 6 of the best indie games from the PAX Australia show floor

Transport costs to Sydney's new airport: Is it worth it for you?

Mino Founder Mel Moss On How Her Son’s Sleep Problems Led To A New Bedding Business

Morning Wrap: ASX 200 to rise, Dow rallies on defensive pivot, S&P 500 gains on oil retreat

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail